Waiting for Platelet Counts Causes Unsubstantiated Delay of Thrombolysis Therapy

Language
en
Document Type
Article
Issue Date
2014-10-29
Issue Year
2013
Authors
Breuer, Lorenz
Huttner, Hagen B.
Kiphuth, Ines-Christine
Ringwald, Jürgen
Hilz, Max Josef
Schwab, Stefan
Köhrmann, Martin
Editor
Abstract

Background: Platelet counts (PCs) <100,000/µl are considered as a contraindication for intravenous thrombolysis (IVT). While US guidelines recommend IVT initiation before the availability of clotting tests, the guidelines of the European Stroke Organization give no such practical advice. We aimed to assess the incidence of thrombocytopenia in IVT patients, outcome after thrombolysis in affected patients and the time gained by initiating treatment prior to availability of PC results. Methods: All patients with thrombocytopenia were identified in our prospectively acquired thrombolysis database. Baseline demographic data, intracerebral hemorrhage rates as well as functional outcome were assessed. The median time between initiation of thrombolysis and availability of PCs was calculated. Results: Of 625 IVT patients, 3 (0.5%) had thrombocytopenia at stroke onset. None of them developed intracerebral hemorrhage (ICH) or died during the follow-up. Waiting for PCs would have delayed treatment in 72.4% of the patients, with a median hypothetical delay of 22 min (interquartile range: 11–41 min). Conclusions: To date, there are no sufficient data to evaluate the ICH risk in thrombocytopenic patients. However, thrombocytopenia is rare in IVT patients. Thus, generally waiting for PC results prior to initiation of IVT is not warranted. Avoiding this significant delay yields shorter door-to-needle times and potentially more effective treatment.

Journal Title
European Neurology
Volume
69
Issue
5
Citation
European Neurology 2013; 69: 317-320. <http://www.karger.com/Article/Pdf/345702> © 2013 S. Karger AG, Basel
DOI
Zugehörige ORCIDs